Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin M Wright

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical Lung Cancer|June 5, 2014
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancerAllison B Ashworth, Suresh Senan, David A Palma, et al.
Journal for Immunotherapy of Cancer|January 20, 2023
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumorsCharles M Rudin, Hardev S Pandha, Matthew Zibelman, et al.
BMJ Open|August 29, 2022
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paperShantelle Smith, Margaret Brand, Susan Harden, et al.
JTO Clinical and Research Reports|April 20, 2026
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality RegistryRob G Stirling, Sanuki Tissera, Jessie Zeng, et al.
Nature Medicine|November 20, 2025
Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Nature Medicine|September 1, 2014
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Genome Biology|February 5, 2015
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing dataLynnette Fernandez-Cuesta, Ruping Sun, Roopika Menon, et al.
Nature Communications|March 28, 2014
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoidsLynnette Fernandez-Cuesta, Martin Peifer, Xin Lu, et al.
Cancer Discovery|January 29, 2014
CD74-NRG1 fusions in lung adenocarcinomaLynnette Fernandez-Cuesta, Dennis Plenker, Hirotaka Osada, et al.
Journal of Thoracic Disease|December 10, 2017
The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomyShugeng Gao, Zhongheng Zhang, Javier Aragón, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical Lung Cancer|June 5, 2014
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancerAllison B Ashworth, Suresh Senan, David A Palma, et al.
Journal for Immunotherapy of Cancer|January 20, 2023
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumorsCharles M Rudin, Hardev S Pandha, Matthew Zibelman, et al.
BMJ Open|August 29, 2022
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paperShantelle Smith, Margaret Brand, Susan Harden, et al.
JTO Clinical and Research Reports|April 20, 2026
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality RegistryRob G Stirling, Sanuki Tissera, Jessie Zeng, et al.
Nature Medicine|November 20, 2025
Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Nature Medicine|September 1, 2014
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Genome Biology|February 5, 2015
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing dataLynnette Fernandez-Cuesta, Ruping Sun, Roopika Menon, et al.
Nature Communications|March 28, 2014
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoidsLynnette Fernandez-Cuesta, Martin Peifer, Xin Lu, et al.
Cancer Discovery|January 29, 2014
CD74-NRG1 fusions in lung adenocarcinomaLynnette Fernandez-Cuesta, Dennis Plenker, Hirotaka Osada, et al.
Journal of Thoracic Disease|December 10, 2017
The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomyShugeng Gao, Zhongheng Zhang, Javier Aragón, et al.
Pageof 7